This ASX 200 healthcare share has a fully franked dividend yield over 4% right now

This ASX 200 healthcare share offers a dividend yield over 4% right now…

Key points
  • The ASX 200 is home to many dividend-paying shares
  • But not too many healthcare shares offer high dividend yields today
  • But let's look at one that is boasting a 4% yield right now...

Sure there are a lot of ASX dividend shares on the S&P/ASX 200 Index (ASX: XJO) to choose from. There are the big banks like Commonwealth Bank of Australia (ASX: CBA). Then there are the mining giants like BHP Group Ltd (ASX: BHP). Other dividend investors look to blue-chips like Telstra Corporation Ltd (ASX: TLS), or Wesfarmers Ltd (ASX: WES) for income. But dividend-paying ASX healthcare shares?

Traditionally, the healthcare space is not one where many investors traditionally search for income. The market's largest healthcare share is CSL Limited (ASX: CSL). But even though CSL shares have fallen more than 8% this year so far, the company still has a dividend yield under 1%.

But there is a healthcare share on the ASX that currently offers a fully franked dividend yield of over 4% right now. That would be Medibank Private Ltd (ASX: MPL).

Medibank Private is the ASX's largest healthcare insurer. Many of us would know its flagship Medibank brand, as well as its AHM subsidiary.

Well, right now, Medibank Private shares offer a dividend yield of 4.06%. Since this yield comes fully franked too, it grosses up to a meaty 5.8% with those franking credits. 

Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

How do Medibank shares offer a 4% yield today?

Where does this yield come from? Well, Medibank's last two dividend payments. The company paid out its interim dividend for FY2022 last month This was a payment of 6.2 cents per share, a healthy rise on the previous interim dividend of 5.8 cents per share. Before that, Medibank doled out a final dividend of 6.9 cents per share in September last year. Again, that was an increase on its 2020 final payment of 6.3 cents per share.

Medibank actually had a bit of a streak going before COVID. From its first ever dividend in 2015, Medibank gave its investors an annual dividend pay raise every year until 2019. 2019 saw the company payout 15.6 cents per share in dividends, but this was reduced to 12 cents in 2020 largely thanks to the effects of the pandemic. 2021 saw the company begin to increase its shareholder payouts once again, which it has continued to do in 2022 so far.

So that's how we get to a 4.06% yield for Medibank shares today. Not too common for an ASX healthcare share at all.

At the current Medibank Private share price, this ASX 200 healthcare share has a market capitalisation of $8.81 billion. 

Motley Fool contributor Sebastian Bowen has positions in Telstra Corporation Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has positions in and has recommended Telstra Corporation Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientists working in the laboratory and examining results.
Healthcare Shares

Neuren Pharmaceuticals shares just hit a 12-month high. There could be more good news to come

This week's sales figures were impressive.

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

Do I still rate CSL shares as a buy after rising 120% in four months?

Let's see if it is too late to buy this biotech giant's shares.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Healthcare Shares

CSL shares push past $200: Is $250 next?

How much further can the CSL share price rally go?

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

ResMed or Cochlear: Which ASX healthcare share would I buy today?

I like both businesses for the long term, but their recent financial performances have given me something to think about.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Could Telix Pharmaceuticals shares double in value over the next 12 months?

Find out if the ASX biotech stock is a buy, sell, or hold now.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

3 compelling reasons to consider buying Mesoblast shares

This company has a lot going on, plus strong revenues.

Read more »

Doctor with stethoscope typing on her computer.
Healthcare Shares

Are CSL shares a buy, hold, or sell at their 52-week high?

Investors have become much more optimistic about its future. But has the share price recovery gone too far?

Read more »

Senior man looking at his laptop and pondering something.
Healthcare Shares

Would I buy ResMed shares after today's results?

The company has reported solid revenue and earnings growth. Here's what I make of its performance and current valuation.

Read more »